Verrill Dana Expands Health Care Practice Group in Massachusetts

July 18, 2016 Press Releases

(July 18, 2016) – Verrill Dana is pleased to welcome Katherine Chaurette and Sarah Trautz as Counsel in the firm's Health Care Practice Group in its Boston, Massachusetts office. With the changing landscape of health care and an increasing demand for legal services, the firm's Health Care Practice Group will now include nearly 20 attorneys.

"These are two of the most talented healthcare attorneys we have had the pleasure of working with over the years and we have been hoping they would be able to join us ever since I first arrived at the firm in 2011," Jeff Heidt the healthcare group's leader commented. "Their arrival at Verrill Dana is a wonderful development for our healthcare practice."

Katherine Chaurette, most recently the Vice President of Legal and Head of Health Law at Sanofi U.S., has extensive experience providing regulatory, compliance and legal analysis and advice related to pharmaceuticals and other areas of the health care industry. Previously, she was also senior counsel at Genzyme Corporation and a partner at Choate, Hall & Stewart where she worked with Mark Borreliz and Jeff Heidt, who are now both at Verrill Dana, for many years. She is a graduate of the University of Rochester and received her law degree from Georgetown University Law Center.

Sarah Trautz previously served as Associate General Counsel at Beth Israel Medical Center and Associate at Ropes & Gray. Like Kathy she too worked with several of the firm's attorneys in her prior employments and earned their deep professional respect. She has experience advising the medical research community on a variety of legal and compliance issues, as well as participating in internal and external investigations for the use of animals in research, the expenditure of federal grant funds, and the tracking of controlled substances. She received her undergraduate degree, magna cum laude, from the University of Pennsylvania and earned her law degree from the University of Virginia School of Law.

Verrill Dana's Health Care Group serves a wide variety of organizations in the healthcare industry and related professions with respect to a wide range of matters including academic and biomedical research, accountable care organizations and managed care, eHealth and health information technology, HIPAA/HITECH privacy and security, Medicare/Medicaid and third-party reimbursement, mergers and acquisitions, and regulatory compliance. Learn more about the group at

Firm Highlights


Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...


Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...


Verrill Welcomes Health Care Attorney Alicia Siani

(February 2, 2021) – Verrill is pleased to welcome health care attorney Alicia Siani to the firm’s Boston, Massachusetts office. Siani represents clients in a wide range of regulatory issues, including HIPAA privacy matters...


HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...


Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.


European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...


Verrill Ranked in American Bar Association’s Health Law Top 10 in the Northeast

(January 19, 2021) – Verrill was recently ranked third in the American Bar Association (ABA) Health Law Section's Eighth Annual Top 10 Recognition for the Northeast Region. This is the sixth consecutive year that...


The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...


Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group. Jeff Smagula brings to Verrill...


Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...

Contact Verrill at (855) 307 0700